PFAS

Global PFAS Screening Tool

No. of Substances: 18960
Ormetoprim
2,4-二氨基-5-(4,5-二甲氧基-2-甲苄基)嘧啶 , 5-(4,5-二甲氧基-2-甲基苄基)-2,4-二氨嘧啶 , 邻里氧普林, UNII-M3EFS94984, 5-((4,5-Dimethoxy-2-methylphenyl)methyl)-2,4-pyrimidinediamine, Ro 5-9754, component of Rofenaid, Ormetoprim, EINECS 230-246-6, MFCD00057747, 2,4-Pyrimidinediamine, 5-[(4,5-dimethoxy-2-methylphenyl)methyl]-, 5-(4,5-Dimethoxy-2-methylbenzyl)-2,4(1H,3H)-pyrimidinediimine, 5-(4,5-Dimethoxy-2-methylbenzyl)pyrimidine-2,4-diamine, 2,4(1H,3H)-Pyrimidinediimine, 5-[(4,5-dimethoxy-2-methylphenyl)methyl]-, 5-(4,5-Dimethoxy-2-methylbenzyl)-2,4-pyrimidinediamine, Ormethoprim, Ormetorprim
CAS Number: 6981-18-6
SMILES: CC1=CC(=C(C=C1CC2=CN=C(N=C2N)N)OC)OC
EC Number: 230-246-6
Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
icon-server
Hot Services
message
in